Domov › Srpastocelična anemija › Ohio
Klinične študije za Srpastocelična anemija v Ohio
22 študij za Srpastocelična anemija išče udeležence na lokacijah v Ohio.
Mesta v Ohio
Uradno besedilo študije (angleško)
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
- Cincinnati Children's Hospital Medical Center, Cincinnati
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07187973A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Univ Hosp Cleveland Med Ctr, Cleveland
- Ohio State Univ Wexner Med Ctr, Columbus
Vključevanje udeležencevFaza 3
Starost 12 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT06612268Sickle Cell Disease Biofluid Chip Technology (SCD BioChip)
- University Hospitals Case Medical Center, Cleveland
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 12 in več · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT02824471A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
- Local Institution - 0028, Cleveland
Vključevanje udeležencevFaza 1/2Vabljeni zdravi prostovoljci
Starost 18 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT06481306ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Akron Children's Hospital - Showers Center for Cancer & Blood Disorders, Akron
- Cincinnati Children's Hospital Medical Center, Hemophilia & Thrombosis Center, Cincinnati
- University of Cincinnati Medical Center Hemophilia Treatment Center, Cincinnati
- in še 5
Vključevanje udeležencevOpazovalna študija
Vse starosti · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- University of Cincinnati, Cincinnati
- The Ohio State University, Columbus
Vključevanje udeležencevFaza 2
Starost 12 in več · Vsi spoli · Posodobljeno 14. avg. 2026 · NCT06699849Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0
- University of Cincinnati College of Medicine, Cincinnati
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 14–80 · Vsi spoli · Posodobljeno 12. avg. 2026 · NCT06725550Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- Ohio State University, Columbus
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 5. avg. 2026 · NCT07224360Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
- Nationwide Children's Hospital, Columbus
Vključevanje udeležencevFaza 1/2
Starost 12–50 · Vsi spoli · Posodobljeno 2. jul. 2026 · NCT04819841Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation
- Cincinnati Children's Hospital Medical Center, Cincinnati
Vključevanje udeležencevOpazovalna študija
Vse starosti · Vsi spoli · Posodobljeno 18. jun. 2026 · NCT04093986Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Nationwide Children's Hospital (NT-DMT), Columbus
Vključevanje udeležencevOpazovalna študija
Starost 3–20 · Vsi spoli · Posodobljeno 4. jun. 2026 · NCT06941389A Socio-ecological Approach for Improving Self-management in Adolescents With SCD
- Cincinnati Children's Hospital Medical Center, Cincinnati
Vključevanje udeležencev
Starost 13–21 · Vsi spoli · Posodobljeno 11. maj 2026 · NCT06290401Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
- The Ohio State University Medical Center, Columbus
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 23. mar. 2026 · NCT06919224Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
- Cincinnati Children's Hospital, Cincinnati
Vključevanje udeležencevFaza 2
Starost 15–40 · Vsi spoli · Posodobljeno 13. mar. 2026 · NCT06260891Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
- Nationwide Children's Hospital, Columbus
Vključevanje udeležencevFaza 2
Starost 2–25 · Vsi spoli · Posodobljeno 10. mar. 2026 · NCT03587272MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease
- UH Seidman Cancer Center Adult SCD Clinic or UH Rainbow Babies and Children's Hospital Sickle Cell Anemia Center, Cleveland
Vključevanje udeležencev
Starost 14 in več · Vsi spoli · Posodobljeno 29. jan. 2026 · NCT06853158A Long-term Follow-up Study in Patients Who Received BEAM-101
- University Hospitals Clevland Medical Center, Cleveland
- The Clevland Clinic Foundation, Cleveland
Vključevanje udeležencevOpazovalna študija
Starost 14–37 · Vsi spoli · Posodobljeno 28. jan. 2026 · NCT07373639Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease
- Cincinnati Children's Hospital Medical Center, Cincinnati
Vključevanje udeležencevOpazovalna študija
6 Months – 6 Years · Vsi spoli · Posodobljeno 21. jan. 2026 · NCT07356050Integrative Training Program for Pediatric Sickle Cell Pain
- Cincinnati Children's Hospital Medical Center, Cincinnati
Vključevanje udeležencev
Starost 12–18 · Vsi spoli · Posodobljeno 14. nov. 2025 · NCT06691867Effectiveness of Nontraditional Hydroxyurea Algorithms: Novel and Clinical Evaluations (ENHANCE)
- Cincinnati Children's Hospital Medical Center, Cincinnati
Vključevanje udeležencevFaza 4
6 Months · Vsi spoli · Posodobljeno 16. sep. 2025 · NCT07177300HPC Offered for PRESERVE Expansion
- The Ohio State University Medical Center, Columbus
Vključevanje udeležencevOpazovalna študija
Starost 12–80 · Vsi spoli · Posodobljeno 28. avg. 2025 · NCT07145411Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
- Cleveland Clinic, Cleveland
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 22. jun. 2025 · NCT06385886Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.